Is the active ingredient in the medication. it is a synthetic form of vitamin d3 (cholecalciferol).
Treatment of vitamin D deficiency and hypoparathyroidism.
Prevention and treatment of osteoporosis in patients at risk.
Treatment of rickets and osteomalacia.
Management of hypocalcemia (low blood calcium levels) in certain conditions.
Calciquick Alfa Cap (Alfacalcidol) acts as a prohormone. Once absorbed into the body, it is converted to calcitriol, the active form of vitamin D. Calcitriol binds to receptors in the intestines, bones, and kidneys, promoting calcium absorption from the gut and regulating calcium and phosphate levels in the blood.
Store alfacalcidol at room temperature, away from light and moisture.
The dosage of alfacalcidol varies depending on the individual's needs and medical condition.
It is typically taken orally, once daily.
Follow your doctor's instructions carefully regarding dosage and frequency.
Hypercalcemia (high blood calcium levels)
Constipation
Nausea
Vomiting
Headache
Bone pain
Weakness
Fatigue
Loss of appetite
Kidney stones
Allergic reactions (rash, itching, swelling).
Consult your doctor about potential interactions between alfacalcidol and alcohol.
Alfacalcidol may cause dizziness or fatigue. Avoid driving or operating machinery if you experience these side effects.
Alfacalcidol should only be used during pregnancy or breastfeeding if the potential benefits outweigh the risks. Consult your doctor for advice.
The use of alfacalcidol in children should be supervised by a healthcare professional.
Patients with kidney problems may need to adjust their dosage or have their calcium levels monitored more closely.
Alfacalcidol is metabolized in the liver. Patients with liver problems may need to adjust their dosage or have their calcium levels monitored more closely.
National Institutes of Health (NIH)
Food and Drug Administration (FDA)
The American Academy of Pediatrics
The National Osteoporosis Foundation
